# Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects

> **NCT02083315** · PHASE1 · COMPLETED · sponsor: **Trevena Inc.** · enrollment: 30 (actual)

## Conditions studied

- Pain, Acute

## Interventions

- **DRUG:** TRV130 1.5 mg
- **DRUG:** TRV130 3 mg
- **DRUG:** TRV130 4.5 mg
- **DRUG:** Morphine 10 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02083315
- **Lead sponsor:** Trevena Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083315, "Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02083315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*